Rinvoq ER 45 MG tablet UU 28S
Ended Awarded
- Contract number
- SPE2DB25FUCH1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,304
Award facts
- Contract value 100% obligated
- $21,303.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,303.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of RINVOQ ER 45 mg tablets (28-count units). This is a non-set-aside contract with an ultimate completion date of September 24, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, has demonstrated substantial capability in fulfilling military medical supply requirements through competitive federal procurement. The company's extensive portfolio of federal contracts with the Defense Logistics Agency encompasses a wide range of pharmaceutical products including specialty medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for RINVOQ, a targeted immunosuppressant medication, reflects the company's role in supporting Defense Health Agency and broader military healthcare operations with essential pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DB25FUCH1?
SPE2DB25FUCH1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FUCH1 worth?
The government has obligated $21,304 on SPE2DB25FUCH1.
Is contract SPE2DB25FUCH1 an order under another contract?
Yes. SPE2DB25FUCH1 is a delivery order under SPE2DB22D1041, an indefinite delivery contract.
Was contract SPE2DB25FUCH1 competed?
The extent of competition for SPE2DB25FUCH1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award